Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2008
11/12/2008CN101304976A Inhibitors of viral replication
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008US20080275250 Factor Viia Inhibitor
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275097 Non-nucleoside reverse transcriptase inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/05/2008EP1988082A1 Polynuclear complex and polymer thereof
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
11/05/2008EP1987009A1 Cyclourea compounds as calcium channel blockers
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430383C Benzimidazoles that are useful in treating sexual dysfunction
11/04/2008US7446165 Provides a functional polymer thin film containing the synthesized benzimidazole polymer; functional polymer thin film is preferred to be doped with phosphoric acid or sulfuric acid, and can be used as an electrolyte of fuel cell
10/2008
10/30/2008WO2008130368A2 Transcription factor modulating compounds and methods of use thereof
10/30/2008WO2008129077A2 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation
10/30/2008WO2008128986A1 Urea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128983A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128981A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128968A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
10/30/2008US20080269298 anticarcinogenic agent, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; for treatment of susceptible neoplasm selected from breast, colon, lung, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma, ovarian, pancreatic, head and neck
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080267879 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
10/30/2008CA2682676A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
10/30/2008CA2656157A1 Transcription factor modulating compounds and methods of use thereof
10/29/2008EP1984343A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/29/2008EP1164121B1 Novel carboxylic acid derivatives and process for producing the same
10/28/2008US7442717 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
10/28/2008US7442716 e.g. 2-[9-chloro-6-(3-hydroxy-3-methylbutyl-1-yn-1-yl)-1H-phenanthro[9,10-d]imidazol-2-yl]-3-fluorobenzonitrile; microsomal prostaglandin E synthase inhibitor; analgesic, antiinflammatory agent; osteoarthritis, rheumatoid arthritis and acute or chronic pain; side effect reducer
10/28/2008US7442673 Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008125589A2 Tris(heterocyclyl) metal complexes as bleach catalysts
10/23/2008WO2008024970A3 Tetrahydroindolone and tetrahydroindazolone derivatives
10/23/2008US20080262063 Novel inhibitors of glutaminyl cyclase
10/23/2008US20080262034 selectively kill tumor cells by altering cancer cell metabolism and signal transduction pathways linked to the Warburg Effect;
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/23/2008DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008CN101291915A Benzimidazole derivatives and their use for modulating the GABAA receptor complex
10/22/2008CN101289485A Absorption of nucleic acids to solid phases under low-salt conditions
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439369 Fuel cells containing hydrogenation catalysts
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7438893 Polybiotin compounds for magnetic resonance imaging and drug delivery
10/21/2008CA2330974C Energy transfer assay method and reagent
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008US20080255367 Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates
10/16/2008US20080255357 Terrylene and Quaterrylene Derivatives
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255133 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008CN101287713A Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
10/15/2008CN101287712A Heterocyclic compounds
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN100425594C PPAR-activating compound and pharmaceutical composition comprising the compound
10/14/2008US7435727 Incubating biomaterial with radiolabeled, photoreactive 2-azetidinone compound; solubilizing and forming eluent of supernatant and wheat germ lectin agarose; separating using column chromatography and gel electrophoresis
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008119754A1 Processes for making zilpaterol and salts thereof
10/09/2008WO2008119721A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119718A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119717A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119666A1 Heterocyclic bridged biphenyls
10/09/2008WO2008064342A3 Pde10 inhibitors and related compositions and methods
10/09/2008US20080249301 Regioselective Process for Preparing Benzimidazole Thiophenes
10/09/2008US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid
10/09/2008US20080248584 Trityl derivatives for enhancing mass spectrometry
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008CA2679991A1 Processes for making zilpaterol and salts thereof
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976835A2 Histone deacetylase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008CN101282929A Compounds and compositions as tpo mimetics
10/08/2008CN100424077C Cyclopentane1,2-diimide preparation method
10/07/2008US7432378 For example, 2-{2-Chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,5-dimethyl-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
10/02/2008WO2008020211A3 Benzimidazole, benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080242644 Therapy, prevention of thromboembolic disease, cancer and rheumatic diseases
10/01/2008CN101277933A Substituted propylamine derivatives and methods of their use
10/01/2008CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
10/01/2008CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/01/2008CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists
09/2008
09/30/2008US7429608 Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 154